The environment surrounding the coronavirus disease 2019 (COVID-19) pandemic seems to change by the minute. The full extent to which HIV-positive individuals can be affected if they contract COVID-19, because they are immunocompromised, is not known. Recently, the CDC issued guidance for this patient population.

The environment surrounding the coronavirus disease 2019 (COVID-19) pandemic seems to change by the minute. The full extent to which HIV-positive individuals can be affected if they contract COVID-19, because they are immunocompromised, is not known. Recently, the CDC issued guidance for this patient population, addressing uncertainty these individual may have in light of the ever-updating trove of available information.

In the document, the CDC addresses these questions:

  • Are people with HIV at higher risk for COVID-19 than other people?
  • What can people with HIV do to protect themselves?
  • Can HIV medicine (antiretroviral therapy [ART]) be used to treat COVID-19?
  • Are shortages of HIV medicine (ART) or pre-exposure prophylaxis (PrEP) expected?
  • What can everyone do to minimize stigma about COVID-19?
CONTINUE READING